CAS No. |
89105-94-2 |
|---|---|
中文名称 |
(2S,5S,11S,14S,17S,20S,29S,32S,35S)-32-[(1H-咪唑-5-基)甲基]-35-氨基-14-(3-氨基-3-氧代丙基)-17-(4-氨基丁基)-5-(羧甲基)-36-(1H-咪唑-5-基)-29-异丁基-2-异丙基-11,20-二甲基-4,7,10,13,16,19,22,25,28,31,34-十一氧代-3,6,9,12,15,18,21,24,27,30,33-十一氮杂六三十烷酸 |
英文名称 |
(2S,5S,11S,14S,17S,20S,29S,32S,35S)-32-((1H-imidazol-5-yl)methyl)-35-amino-14-(3-amino-3-oxopropyl)-17-(4-aminobutyl)-5-(carboxymethyl)-36-(1H-imidazol-5-yl)-29-isobutyl-2-isopropyl-11,20-dimethyl-4,7,10,13,16,19,22,25,28,31,34-undecaoxo-3,6,9,12,15,18,21,24,27,30,33-undecaazahexatriacontanoic acid |
别名 |
FIBRINOGEN Y-CHAIN DODECAPETIDE;FIBRINOGEN GAMMA-CHAIN DODECAPEPTIDE;FIBRINOGEN-BINDING INHIBITOR PEPTIDE;HUMAN FIBRINOGEN-GAMMA FRAGMENT 400-411;HHLGGAKQAGDV;H-HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL-OH;HIS-HIS-LEU-GLY-GLY-ALA-LYS-GLN-ALA-GLY-ASP-VAL;fibrinogen-γ fragment 400-411 |
标准英文名 |
(2S,5S,11S,14S,17S,20S,29S,32S,35S)-32-((1H-imidazol-5-yl)methyl)-35-amino-14-(3-amino-3-oxopropyl)-17-(4-aminobutyl)-5-(carboxymethyl)-36-(1H-imidazol-5-yl)-29-isobutyl-2-isopropyl-11,20-dimethyl-4,7,10,13,16,19,22,25,28,31,34-undecaoxo-3,6,9,12,15,18,21,24,27,30,33-undecaazahexatriacontanoic acid |
MDL No. |
MFCD00167528 |
分子式 |
C50H80N18O16 |
分子量 |
1189.30 |
精确分子量 |
1188.60 |
SMILES |
CC(C)C[C@H](NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H](N)CC1=CN=CN1)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C |
标准SMILES |
C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H](N)CC1=CN=CN1)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O |
用途 |
Fibrinogen-binding inhibitor peptide (HHLGGAKQAGDV, H12) is used to bind fibrinogen, inhibit platelet adhesion to fibrinogen, suppress platelet aggregation, and inhibit platelet adhesion to fluorothiazine; it also serves as a specific binding site for ligands of activated glycoprotein (GP) IIb/IIIa. |
InChIKey |
STSKWZSBFZRSGP-GYDGUXFESA-N |
|
|
评论 |
|---|